Under the agreement, Syngenta will evaluate KOMO’s non-viral, integrase-based genome engineering technology for research applications focused on the controlled and predictable introduction of genetic ...

Chinese scientists, with the aim of enhancing leukemia treatment, have developed a kind of "double-sided tape" that helps the ...

Strain hunters The laboratory for infections with a natural reservoir at the Republican Centre for Hygiene, Epidemiology ...

As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.

Cytotrait is developing crop engineering technology for precise gene editing in plant organelles to enable crops with ...

The oncology monoclonal antibodies market presents opportunities through technological advancements, new product launches, and growing patient awareness. Expanding cancer prevalence, innovative drug ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices, epidermolysis bullosa emerging drugs, market share of individual ...

The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...

On the brink of the first genetically engineered (GE) wheat to be introduced into the U.S. market, after the U.S. Department ...

Picture this: You're signing a credit card receipt at the bank, using one of those pens attached to a short chain. As a ...

Walking through Ballyannan Woods recently, I was stopped in my tracks by a sound that felt oddly out of place. A sharp, rapid ...